Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) shares were down 4.5% on Tuesday . The stock traded as low as C$1.70 and last traded at C$1.70. Approximately 295 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 4,135 shares. The stock had previously closed at C$1.78.
Genscript Biotech Trading Down 4.5 %
The business’s 50-day moving average price is C$1.51 and its two-hundred day moving average price is C$1.41.
Genscript Biotech Company Profile
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Further Reading
- Five stocks we like better than Genscript Biotech
- Stock Splits, Do They Really Impact Investors?
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- How to Use Stock Screeners to Find Stocks
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What is the Shanghai Stock Exchange Composite Index?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
